EUVIMEDEUVIMED entdecken
Crossref

Pellitorine protects chronic restraint stress-induced cognitive deficits via inhibiting neural inflammation and ferroptosis

Jia-Bao Zhang, Guo-Dong Lu, Dan-Ni Sun, Peng Ding, Ya-Kun Chen, Yan-Yan Zhou, Yi-Ting Chen, Mudan Cai, Jong Hoon Ryu, Pei Wang, Yong-Ping Liang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Jia-Bao Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Fatty Acids, Unsaturated, Polyunsaturated Alkamides, Ferroptosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: It has not been known that pellitorine, an active ingredient of Piper sarmentosum Roxb. with therapeutic effects against epilepsy and anxiety disorders, has the neurological effects. Our study aimed to investigate the therapeutic potential of pellitorine in addressing chronic restraint stress (CRS)-associated cognitive deficits. METHODS: The CRS mouse model was treated with pellitorine and subjected to depression-like behavior assessments. Neuronal survival was evaluated through histological and Nissl staining. Immunoblotting assays were conducted to examine the expression levels of signaling pathway proteins. Immunofluorescent staining, flow cytometry, and RNA sequencing were utilized to further elucidate the pathological and molecular changes in pellitorine-treated CRS mice. RESULTS: Behavioral experiments demonstrated that pellitorine treatment significantly alleviated depression-like behaviors and improved cognitive function in CRS mice. Histological analysis revealed a marked reduction in neuronal loss following pellitorine administration. Transcriptomic profiling indicated that pellitorine suppressed ferroptosis-associated signaling pathways and neuroinflammation. Notably, the expression of anti-ferroptosis factors, including GPX4, DHODH, and FSP1, was decreased in CRS mice but restored by pellitorine treatment. In addition, pellitorine prevented neuronal loss, preserved the expression of neuroprotective molecules such as BDNF, Nrf2, HO-1, phosphorylated-CREB, and phosphorylated-ERK1/2, and reduced the protein levels of inflammation-related markers including NLRP3, HMGB1, and NF-κB. Immunofluorescent staining and flow cytometry analyses further showed that pellitorine treatment reduced the number of activated microglia, as indicated by decreased Iba-1+, TREM2+, CD86+, and CX3CR1+ cell populations in the hippocampus. Importantly, pellitorine did not exhibit any observable neurotoxic effects in healthy control mice. CONCLUSIONS: Our findings demonstrate that pellitorine protects against CRS-induced cognitive deficits, neural inflammation, and ferroptosis, highlighting its promise as a therapeutic agent for mental health issues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionFatty Acids, UnsaturatedPolyunsaturated AlkamidesFerroptosisNeuroinflammatory DiseasesStress, PsychologicalAnimalsMiceRestraint, PhysicalPiperDepressionNeuronsNeuroprotective AgentsMaleMice, Inbred C57BL

Stichwörter der Autor:innen

Cognitive impairmentDepressionFerroptosisMicrogliaNeuroinflammationPellitorine

Substanzen

pellitorineFatty Acids, UnsaturatedPolyunsaturated AlkamidesNeuroprotective Agents

Autor:innen und Institutionen

  • Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Naval Medical University, Shanghai, China.
  • Department of Anesthesiology, PLA No. 983 Hospital, Tianjin, China.
  • Department of Neurosurgery, The First Medical Center of PLA General Hospital, Beijing, China.
  • Department of KM Science Research Division, Korea Institute of Oriental Medicine (KIOM), Daejeon, South Korea.
  • Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea. Electronic address: jhryu63@khu.ac.kr.
  • Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Naval Medical University, Shanghai, China. Electronic address: pwang@smmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J. B., Lu, G. D., Sun, D. N., Ding, P., Chen, Y. K., Zhou, Y. Y., Chen, Y. T., Cai, M., Ryu, J. H., Wang, P., & Liang, Y. P. (2025). Pellitorine protects chronic restraint stress-induced cognitive deficits via inhibiting neural inflammation and ferroptosis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115166

Vancouver

Zhang JB, Lu GD, Sun DN, Ding P, Chen YK, Zhou YY, et al. Pellitorine protects chronic restraint stress-induced cognitive deficits via inhibiting neural inflammation and ferroptosis. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115166

BibTeX
@article{Zhang2025,
  author = {Zhang, Jia-Bao and Lu, Guo-Dong and Sun, Dan-Ni and Ding, Peng and Chen, Ya-Kun and Zhou, Yan-Yan and Chen, Yi-Ting and Cai, Mudan and Ryu, Jong Hoon and Wang, Pei and Liang, Yong-Ping},
  title = {Pellitorine protects chronic restraint stress-induced cognitive deficits via inhibiting neural inflammation and ferroptosis},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115166}
}
Kostenlos starten →